(Q21710682)

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Consequences of declining survey response rates for smoking prevalence estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Development and validation of the Neuropathic Pain Symptom Inventory

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Can pain be more or less neuropathic?

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

The epidemiology of chronic pain in the community

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Chronic pain in Australia: a prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

The course of chronic pain in the community: results of a 4-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Presentation of pain drawings in questionnaire surveys: influence on prevalence of neck and upper limb pain in the community

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Prevalence of chronic benign pain disorder among adults: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Assessment and treatment of neuropathic cancer pain following WHO guidelines

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Investigation of an opioid response categorization in advanced cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

The Level of Expressed Need-a measure of help-seeking behaviour for chronic pain in the community

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Neuropathic pain: evidence matters

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

The 'number needed to sample' in primary care research. Comparison of two primary care sampling frames for chronic back pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Neurogenic pain syndromes and their management

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPAIN.2005.11.008

7 January 2021